Medicus Pharma Debt/Equity Ratio 1971-1970 | MDCX

Medicus Pharma debt/equity ratio from 1971 to 1970. Debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity.

Medicus Pharma Debt/Equity Ratio 1971-1970 | MDCX

Medicus Pharma debt/equity ratio from 1971 to 1970. Debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity.
Related Stocks
Company NameMarket
Cap
Amgen (AMGN)$149.5B
Bristol Myers Squibb (BMY)$121.6B
Vertex Pharmaceuticals (VRTX)$119.9B
Gilead Sciences (GILD)$117.2B
CSL (CSLLY)$88.1B
Regeneron Pharmaceuticals (REGN)$83.8B
GSK (GSK)$71.1B
Argenex SE (ARGX)$37.3B
Alnylam Pharmaceuticals (ALNY)$32.6B
BioNTech SE (BNTX)$28.1B
Biogen (BIIB)$23.9B
Illumina (ILMN)$23B
BeiGene (BGNE)$20B
Moderna (MRNA)$17B
Genmab (GMAB)$14.5B
Incyte (INCY)$14.1B
Insmed (INSM)$13B
BioMarin Pharmaceutical (BMRN)$12.4B
Sarepta Therapeutics (SRPT)$12.2B
Bio-Techne Corp (TECH)$12.1B
Exact Sciences (EXAS)$11.4B
Vaxcyte (PCVX)$11.4B
Exelixis (EXEL)$10.2B
QIAGEN (QGEN)$10B
Bio-Rad Laboratories (BIO.B)$9.4B
Intra-Cellular Therapies (ITCI)$9.1B
Roivant Sciences (ROIV)$9.1B
Revolution Medicines (RVMD)$8.7B
Repligen (RGEN)$8.4B
Ascendis Pharma (ASND)$8.1B